Zacks Investment Research on MSN21d
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product development. The optimism, led by decent 2024 preliminary results and restructuring ...
pharmaphorum1y
PacBio builds in short-read sequencing with $110m Apton buy
PacBio also revealed in its second-quarter results update that it has started rolling out a new short-read sequencing benchtop instrument called Onso that will make use of the SBB technology.
Nasdaq29d
PacBio Advances Genomic Sequencing with Timely Launch of Vega™ Benchtop System and SPRQ Chemistry Despite Revenue Decline
PacBio products or technologies, including Revio, Vega and Onso; and other future events. Reported results and orders for Revio and Vega should not be considered an indication of future ...
Morningstar9d
PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service
MENLO PARK, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David ...
Yahoo Finance29d
PacBio Announces Preliminary Fourth Quarter and Full Year Revenue
MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced preliminary unaudited revenue for ...
The Business Journals13d
Menlo Park-based biotech company welcomes Florida exec to board
The company is known for pioneering DNA sequencing. Chris Smith, CEO of oncology diagnostic company NeoGenomics Inc., is getting a seat on the board of Pacific Biosciences of California Inc ...